<p>A new predictor is comparable to the updated nomogram in predicting the intermediate- and high-risk prostate cancer but outperforms nomogram in reducing the overtreatment for the low-risk Pca</p>

Original Research

A new predictor is comparable to the updated nomogram in predicting the intermediate- and high-risk prostate cancer but outperforms nomogram in reducing the overtreatment for the low-risk Pca

Total article views		HTML views	PDF downloads	Totals
4,354	Dovepress*	4,077+	851	4,928
	PubMed Central*	277	104	381
	Totals	4,354	955	5,309
*Since 30 April 2019